These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12941424)

  • 1. Beyond Herceptin and Gleevec.
    Fischer OM; Streit S; Hart S; Ullrich A
    Curr Opin Chem Biol; 2003 Aug; 7(4):490-5. PubMed ID: 12941424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Researchers optimistic about sea change in cancer treatment.
    Stephenson J
    JAMA; 2001 Jun; 285(22):2841-2. PubMed ID: 11401587
    [No Abstract]   [Full Text] [Related]  

  • 3. Smart drugs: tyrosine kinase inhibitors in cancer therapy.
    Shawver LK; Slamon D; Ullrich A
    Cancer Cell; 2002 Mar; 1(2):117-23. PubMed ID: 12086869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting tyrosine kinases: successes and limitations.
    Arteaga CL
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S79-83. PubMed ID: 14508084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antineoplastic agents targeting tyrosine kinases].
    Guren TK; Christoffersen T; Thoresen GH; Wisløff F; Dajani O; Tveit KM
    Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3115-9. PubMed ID: 16299568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting tyrosine kinases in cancer: the second wave.
    Baselga J
    Science; 2006 May; 312(5777):1175-8. PubMed ID: 16728632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage.
    Petrelli A; Giordano S
    Curr Med Chem; 2008; 15(5):422-32. PubMed ID: 18288997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer treatment. New drugs, new hope.
    Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent advances of molecular targeted agents: opportunities for imaging.
    Dancey JE
    Cancer Biol Ther; 2003; 2(6):601-9. PubMed ID: 14688462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase inhibitors: a clinical perspective.
    Goel S; Mani S; Perez-Soler R
    Curr Oncol Rep; 2002 Jan; 4(1):9-19. PubMed ID: 11734109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
    Kim R; Toge T
    Surg Today; 2004; 34(4):293-303. PubMed ID: 15052442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular therapy of breast carcinoma in the advanced phase].
    Foggi P; Amodio A
    Tumori; 2003; 89(4 Suppl):189-91. PubMed ID: 12903589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004.
    Caponigro F; Basile M; de Rosa V; Normanno N
    Anticancer Drugs; 2005 Feb; 16(2):211-21. PubMed ID: 15655420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinases as targets for anticancer agents: from inhibitors to useful drugs.
    Fabbro D; Ruetz S; Buchdunger E; Cowan-Jacob SW; Fendrich G; Liebetanz J; Mestan J; O'Reilly T; Traxler P; Chaudhuri B; Fretz H; Zimmermann J; Meyer T; Caravatti G; Furet P; Manley PW
    Pharmacol Ther; 2002; 93(2-3):79-98. PubMed ID: 12191602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular targeted therapy].
    Stenner-Liewen F; Zippelius A; Pestalozzi BC; Knuth A
    Chirurg; 2006 Dec; 77(12):1118-25. PubMed ID: 17109101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapies for the treatment of cancer.
    Kim JA
    Am J Surg; 2003 Sep; 186(3):264-8. PubMed ID: 12946830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tyrosine kinases. New target of anticancer therapy].
    Majsterek I; Pytel D; Błasiak J
    Postepy Biochem; 2005; 51(3):251-60. PubMed ID: 16381169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.
    Becker JC; Muller-Tidow C; Serve H; Domschke W; Pohle T
    World J Gastroenterol; 2006 Jun; 12(21):3297-305. PubMed ID: 16733844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mechanisms of the resistance to molecular targeting agents].
    Akiyama S
    Nihon Rinsho; 2004 Jul; 62(7):1297-304. PubMed ID: 15283147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.